CG
FBIO icon

Cutler Group’s Fortress Biotech FBIO Stock Holding History

Cutler Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80
Closed -$1K – 5171
2022
Q1 		$1K Buy
+80
New +$2.19K ﹤0.01% 4950
2021
Q3 		– Sell
-333
Closed -$1K – 5883
2021
Q2 		$1K Buy
+333
New +$20.1K ﹤0.01% 5274
2017
Q1 		– Sell
-67
Closed -$2K – 6600
2016
Q4 		$2K Buy
+67
New +$2.5K ﹤0.01% 5586
2016
Q3 		– Sell
-33
Closed -$1K – 6861
2016
Q2 		$1K Buy
+33
New +$1.54K ﹤0.01% 6045

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cutler Group's FBIO Position: Q4 2023 in Review

Cutler Group sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 267 shares — an estimated $1K sold.

Cutler Group first reported a position in FBIO in Q4 2015 and held it in 32 quarters. The position peaked at $60K in Q1 2017. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • Cutler Group reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 267 Fortress Biotech shares in Q4 2023, an estimated $1K.
  • Cutler Group first reported a position in Fortress Biotech in Q4 2015 and held it in 32 quarters.
  • Cutler Group's Fortress Biotech position peaked at $60K in Q1 2017.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.